NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Medical Patent Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Legal Issues



Conor Medsystems announces decision from U.K. Court of Appeal



February 14th, 2007

Conor Medsystems, Inc. (CONR) announced that the Court of Appeal in the United Kingdom unanimously upheld the decision of the High Court of Justice to revoke the U.K. portion of European Patent (EP) 0 706 376 B1 to Angiotech Pharmaceuticals, Inc.

The patent is exclusively licensed to Boston Scientific Corporation for use in the field of coronary stents.

On February 18, 2005, Conor Medsystems initiated proceedings against Angiotech and the University of British Columbia in the High Court of Justice in the United Kingdom requesting that the court invalidate EP 0 706 376 B1 based on the grounds that all claims of the patent either lack novelty or are...


Source: Medical Patent Law Weekly (2007-02-14)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login